Strontium is a mineral that is similar to the physical and chemical properties of calcium. Research has shown strontium to provide all natural bone support through its ability to increase the formation of osteoblasts while decreasing the formation of osteoclasts.
Nearly 99% of the calcium within the adult skeletal system exists as a complex paired with phosphorus, called hydroxyapatite. It is commonly advised that individuals past early adolescence consume 1,000 to 1,500 mg/ day from dietary or supplement sources to support bone formation. Pro Bono is formulated with calcium citrate-malate, as well as calcium hydroxyapatite, to improve absorption and support optimal bone health.
Magnesium plays a major role in bone formation as approximately 50% of magnesium found in the body is found in the bone. Magnesium plays numerous roles in bone health including increasing calcium absorption, acting as a cofactor for alkaline phosphatase activation, as well as supporting vitamin D3 conversion in the body. Magnesium deficiency is very common–many Americans fail to acquire even the estimated average requirement (EAR). Magnesium deficiency can also be exacerbated due to factors such as excess consumption of alcohol, salt, coffee, phosphoric acid in sodas, and long-term stress.
Vitamin D3 (Cholecalciferol)
Vitamin D is a steroid vitamin that is known for its role in supporting bone health and aiding in the absorption of calcium and phosphate from the GI tract.
Vitamin K1 (Phytonedione) & Vitamin K2 (Menaquinone)
Vitamin K is responsible for synthesizing osteocalcin, a protein involved in calcium transport and properly embedding calcium into bone tissue. Vitamin K has also been shown to decrease the activity of osteoclasts, which helps to maintain bone formation and strength. Vitamin K works synergistically with vitamin D3 to improve calcium absorption and helps to bind newly absorbed calcium to the bone matrix.
Boron supplementation reduced urinary excretion of calcium and magnesium and increased blood levels of 17 betaestradiol and testosterone in postmenopausal women in one study. Improving boron levels has been shown to support bone health
Pro Bono product data sheet
1. Reginster, J Y, Deroisy, R. et al. Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial. Osteoporos Int 2002; 13(12):925-931.
2. Cianferotti L, D’Asta F, Brandi ML. A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther Adv Musculoskelet Dis 2013 Jun;5(3):127-39.
3. Patrick Lyn. Comparative absorption of calcium sources and calcium citrate malate prevention for osteoporosis. Altern Med Review 1999;4(2):74-85.
4. Moshfegh A, Goldman J, Ahuja J, Rhodes D, LaComb R. 2009. What We Eat in America, NHANES 2005-2006: Usual Nutrient Intakes from Food and Water Compared to 1997 Dietary Reference Intakes for Vitamin D, Calcium, Phosphorus, and Magnesium. U.S. Department of Agriculture, Agricultural Research Service.
5. Johnson S. The multifaceted and widespread pathology of magnesium deficiency. Med Hypotheses 2001; 56(2): 163-70.
6. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993; 6:155-163.
7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84:18-26.
8. Wamberg L, Pedersen SB, Richelsen B, Rejnmark L. The effect of high-dose vitamin d supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlledstudy. Calcif Tissue Int 2013 Jul;93(1):69-77.
9. Cauley JA, Lacroix AZ, Wu L, Horwitz M, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008 Aug 19;149(4):242-50.
10. Weber P. Management of osteoporosis: is there a role for vitamin K? Int J Vitam Nutr Res 1997;67(5):350-6.
11. Braam LA, Knapen MH et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 2003 Jul;73(1):21-6.
12. Nielson FH. Boron: an overlooked element of potential nutritional importance. Nutr Today 1988;Jan/Feb:4-7.
13. Nielsen FH. The justification for providing dietary guidance for the nutritional intake of boron. Biol Trace Elem Res 1998 Winter;66(1-3):319-30.
14. Strause l, Saltman P, Smith KT, et al. Spical bon eloss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060:1064.